Cargando…
Outcome of CentriMag™ extracorporeal mechanical circulatory support use in critical cardiogenic shock (INTERMACS 1) patients
PURPOSE: Prognosis of patients presenting with INTERMACS 1 critical cardiogenic shock is generally poor. The aim of our study was to investigate the results of CentriMag™ extracorporeal short-term mechanical circulatory support as a bridge to decision in patients presenting with critical cardiogenic...
Autores principales: | Mehta, Vipin, Venkateswaran, Rajamiyer V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526512/ https://www.ncbi.nlm.nih.gov/pubmed/33020688 http://dx.doi.org/10.1007/s12055-020-01060-6 |
Ejemplares similares
-
Use of CentriMag for refractory cardiogenic shock in a puerperal woman: case report
por: Pêgo-Fernandes, Paulo Manuel, et al.
Publicado: (2021) -
Extracorporeal Life Support and Temporary CentriMag Ventricular Assist Device to Salvage Cardiogenic-Shock Patients Suffering from Prolonged Cardiopulmonary Resuscitation
por: Chen, Jia-Lin, et al.
Publicado: (2022) -
Thoratec CentriMag for Temporary Treatment of Refractory Cardiogenic Shock or Severe Cardiopulmonary Insufficiency: A Systematic Literature Review and Meta-Analysis of Observational Studies
por: Borisenko, Oleg, et al.
Publicado: (2014) -
Hemocompatibility of new magnetically-levitated centrifugal pump technology compared to the CentriMag adult pump
por: Schibilsky, David, et al.
Publicado: (2020) -
How to Optimize ECLS Results beyond Ventricular Unloading: From ECMO to CentriMag(®) eVAD
por: Tarzia, Vincenzo, et al.
Publicado: (2022)